SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (8546)5/30/2003 3:02:04 PM
From: Biomaven  Respond to of 52153
 
I've was looking at CVTX wondering why such strength. (I'm not complaining as this is a significant holding for me and I've always believed that the ranolazine QTc issues were overblown.)

Finally I thought to look on the CVTX thread and quickly realized that Miljenko and Wilder were a good few steps ahead of me:

Message 18986188

and Wilder's reply.

I believe the ranolozine QTc prolongation is apparently in the 2-5msce range, also with no arrythmia ever detected.

Peter